Proficio Capital Partners LLC Has $589,000 Holdings in Danaher Co. (NYSE:DHR)

Proficio Capital Partners LLC boosted its position in shares of Danaher Co. (NYSE:DHR) by 28.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,566 shares of the conglomerate’s stock after buying an additional 562 shares during the quarter. Proficio Capital Partners LLC’s holdings in Danaher were worth $589,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Heck Capital Advisors LLC acquired a new position in Danaher during the 4th quarter worth $27,000. Decker Retirement Planning Inc. acquired a new position in Danaher during the 4th quarter worth $31,000. Golden State Wealth Management LLC acquired a new position in Danaher during the 4th quarter worth $31,000. Teachers Insurance & Annuity Association of America acquired a new position in Danaher during the 3rd quarter worth $39,000. Finally, Pineridge Advisors LLC lifted its holdings in Danaher by 63.3% during the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after buying an additional 57 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analysts Set New Price Targets

DHR has been the topic of several research reports. Citigroup reduced their price objective on Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a report on Thursday, January 30th. StockNews.com downgraded Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Barclays cut their price target on Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a research note on Thursday, January 30th. The Goldman Sachs Group raised Danaher from a “neutral” rating to a “buy” rating and set a $260.00 price target on the stock in a research note on Friday. Finally, Robert W. Baird cut their price target on Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Five research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $278.24.

Danaher Price Performance

DHR opened at $211.63 on Monday. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70. The company has a fifty day simple moving average of $217.46 and a 200 day simple moving average of $238.50. The stock has a market cap of $151.26 billion, a P/E ratio of 40.08, a P/E/G ratio of 2.66 and a beta of 0.82.

Danaher (NYSE:DHR) last released its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the previous year, the company posted $2.09 earnings per share. On average, research analysts expect that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.60%. The ex-dividend date is Friday, March 28th. This is a boost from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio is 24.24%.

Insiders Place Their Bets

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 11.10% of the company’s stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.